Product Images Tyenne
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Tyenne NDC 65219-592 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure - tye00 0000 01
Principal Display Panel – 80 mg /4 mL Vial carton - tye00 0000 02
This is a description for the medication "Tocilizumab-aazg", which is administered via intravenous infusion. The medication comes in a single-dose vial containing 80 mg of the active ingredient. The inactive ingredients include Arginine, Histidine, Lactic acid, Polysorbate 80, and Sodium chloride in Water for Injection USP. It is recommended to store the medication refrigerated at 36°F to 46°F and protect it from light, freezing, or shaking. The prescribing information provides details regarding the recommended dosage. The carton also includes a Medication Guide for each patient. It is important to contact a doctor for medical advice about any side effects. Additionally, the medication is manufactured by Fresenius Kabi USA LLC and is a product of Austria.*
Principal Display Panel – 200 mg /10 mL Vial carton - tye00 0000 03
This text provides detailed information about a medication called Tocilizumab-aazg, available in an injectable form with 200 mg/10 ml strength for intravenous infusion. The packaging consists of a single-dose vial containing the active ingredient Tocilizumab-aazg and other inactive ingredients. It includes instructions on dosage, storage at a refrigerated temperature, and advice on reporting side effects. The product is manufactured by Fresenius Kabi and should not be used if the seal is broken or missing. Overall, this text serves as a guide for healthcare providers and patients on the proper use of Tocilizumab-aazg.*
Principal Display Panel – 400 mg /20 mL Vial carton - tye00 0000 04
This text is detailing the information related to a medication named "Tyenne" in the form of an injection containing tocilizumab-aazg at a concentration of 400 mg per 20 mL. It is meant for intravenous infusion only after dilution. The package includes a single-dose vial, Prescribing Information, and Medication Guide. The storage instructions advise refrigeration between 36°F to 46°F to protect the product. The contents of the vial include active and inactive ingredients listed, and it emphasizes the importance of following the prescribed dosage. The medication is manufactured by Fresenius Kabi and requires refrigeration immediately after purchase to maintain its sterile solution without preservatives.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.